Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cellular Adaptation II: Hypertrophy01:26

Cellular Adaptation II: Hypertrophy

Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improving the diagnostic performance of troponin assays for acute myocardial infarction in renal impairment.

Heart (British Cardiac Society)·2026
Same author

From Mechanics to Mitochondria: Dyssynchronous Heart Failure as an Energetic Disease.

European journal of heart failure·2026
Same author

Investigating prognostic classifications of preexisting multiple long-term conditions for health outcomes 1 year after COVID-19 hospitalization: A UK prospective observational study.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026
Same author

Point-of-care testing for pre-hospital stratification after out-of-hospital cardiac arrest: the RAPID-MIRACLE study.

European heart journal. Acute cardiovascular care·2026
Same author

COVID-19 and elevated coronary thrombus burden - a persistent risk even after recovery?

Cardiology journal·2026
Same author

Prospective Validation of the MIRACLE<sub>2</sub> Score for Early Neurological Stratification After Out-of-Hospital Cardiac-Arrest: The GLOBAL-MIRACLE Registry.

Circulation. Cardiovascular interventions·2026

Related Experiment Video

Updated: Jun 8, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

Genome-wide expression patterns in physiological cardiac hypertrophy.

Ignat Drozdov1, Sophia Tsoka, Christos A Ouzounis

  • 1King's College London (KCL) BHF Centre of Research Excellence - Cardiovascular Division - School of Medicine - James Black Centre - 125 Coldharbour Lane, London, UK.

BMC Genomics
|October 13, 2010
PubMed
Summary
This summary is machine-generated.

This study analyzed gene co-expression patterns in physiological cardiac hypertrophy, revealing conserved pathways for cell survival and blood vessel formation. These findings offer new molecular insights into cardiac adaptation.

More Related Videos

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
10:22

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse

Published on: October 26, 2017

Related Experiment Videos

Last Updated: Jun 8, 2026

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level
06:02

An Approach to Study Shape-Dependent Transcriptomics at a Single Cell Level

Published on: November 2, 2020

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse
10:22

Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse

Published on: October 26, 2017

Area of Science:

  • Cardiovascular Biology
  • Molecular Biology
  • Systems Biology

Background:

  • Investigates genome-wide expression patterns in physiological cardiac hypertrophy.
  • Examines co-expression patterns during cardiac adaptation.

Purpose of the Study:

  • To conduct the first large-scale network analysis of publicly available genome-wide expression data in murine models of physiological left ventricular hypertrophy (LVH).
  • To identify conserved molecular pathways and novel gene networks involved in physiological cardiac adaptation.

Main Methods:

  • Utilized network analysis on over 3 million gene co-expression patterns.
  • Analyzed data from 141 microarray experiments across multiple in vivo murine models.
  • Applied network inference to determine topological and functional properties of gene networks.

Main Results:

  • Identified conserved processes in physiological adaptation, including cytochrome c oxidase function preservation and autophagy induction for cell survival.
  • Revealed coordinated regulation of angiogenesis as a key component of cardiac adaptation.
  • Uncovered novel networks of co-expressed genes underlying the physiological hypertrophy phenotype.

Conclusions:

  • The study successfully identified known and novel biological pathways implicated in physiological LVH.
  • Provides new insights into the molecular mechanisms governing cardiac adaptation through network analysis.
  • Highlights the evolutionary conservation of adaptive processes in the heart.